Aquinox to Present at 2018 UBS Global Healthcare Conference
May 16 2018 - 1:32PM
Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a
clinical-stage pharmaceutical company discovering and developing
novel drug candidates to treat inflammation, inflammatory pain, and
blood cancers, announced today that David Main, President &
CEO, will provide a corporate update at the upcoming
2018
UBS Global Healthcare Conference in New
York on
Wednesday, May 23rd 2018.
Aquinox Presentation Details
Date: Wednesday, May 23rd 2018
Time: 5:00 am Pacific Time / 8:00 am Eastern
Time
Location: New York, NY – Grand Hyatt New York
A live webcast and archive of the event will be available
at:
https://cc.talkpoint.com/ubsx001/052118a_as/?entity=75_XVWH8N7
To ensure a timely connection to the webcast, it is recommended
that users register at least 15 minutes prior to the scheduled
start time. An archived version of the webcast will also be
available on the Investor Relations page of the Aquinox website.
The corporate overview being presented will be available following
the presentation at www.aqxpharma.com.
About Aquinox
Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. is a clinical-stage
pharmaceutical company developing novel therapeutics for chronic
urological conditions marked by inflammation and pain. Aquinox's
lead drug candidate, rosiptor (AQX-1125), is in Phase 3 development
for the treatment of patients with interstitial cystitis/bladder
pain syndrome (IC/BPS), a condition for which there are currently
few FDA approved and/or effective treatment options.
Aquinox is focused on leveraging its library of novel compounds
that activate SHIP1 to develop therapeutics for application in
inflammation, inflammatory pain, and blood cancers. For more
information, please visit http://www.aqxpharma.com/.
Investor Contact
Info:
Brendan
Payne
Associate Director, Investor Relations Aquinox Pharmaceuticals,
Inc.604.901.3019ir@aqxpharma.com
Gitanjali OgawaVice
President The Trout
Group
646-378-2949
Gogawa@troutgroup.com
Aquinox Pharmaceuticals (NASDAQ:AQXP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aquinox Pharmaceuticals (NASDAQ:AQXP)
Historical Stock Chart
From Jul 2023 to Jul 2024